Loews Co. (NYSE:L – Get Rating) major shareholder Corp Loews bought 50,789 shares of the business’s stock in a transaction dated Tuesday, September 13th. The shares were bought at an average cost of $39.42 per share, for a total transaction of $2,002,102.38. Following the completion of the transaction, the insider now directly owns 243,577,388 shares of the company’s stock, valued at $9,601,820,634.96. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Major shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.
Corp Loews also recently made the following trade(s):
- On Thursday, September 15th, Corp Loews purchased 50,789 shares of Loews stock. The shares were acquired at an average price of $38.44 per share, for a total transaction of $1,952,329.16.
- On Thursday, September 8th, Corp Loews purchased 47,899 shares of Loews stock. The shares were acquired at an average price of $40.08 per share, for a total transaction of $1,919,791.92.
- On Tuesday, September 6th, Corp Loews purchased 48,199 shares of Loews stock. The shares were acquired at an average price of $39.56 per share, for a total transaction of $1,906,752.44.
Loews Stock Performance
Shares of NYSE L opened at $53.96 on Friday. The business’s 50-day moving average price is $56.82 and its two-hundred day moving average price is $60.65. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.35 and a quick ratio of 0.35. Loews Co. has a one year low of $51.35 and a one year high of $68.20. The company has a market capitalization of $13.00 billion, a P/E ratio of 12.52 and a beta of 0.81.
Loews Announces Dividend
Analyst Ratings Changes
A number of research analysts have recently weighed in on L shares. StockNews.com downgraded Loews from a “buy” rating to a “hold” rating in a report on Wednesday, August 3rd. TheStreet downgraded Loews from a “b” rating to a “c” rating in a report on Monday, August 1st.
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of L. Brown Advisory Inc. boosted its stake in shares of Loews by 9.2% during the 2nd quarter. Brown Advisory Inc. now owns 7,145 shares of the insurance provider’s stock worth $417,000 after acquiring an additional 600 shares in the last quarter. Amundi boosted its stake in shares of Loews by 16.5% during the 2nd quarter. Amundi now owns 467,578 shares of the insurance provider’s stock worth $26,003,000 after acquiring an additional 66,158 shares in the last quarter. Captrust Financial Advisors boosted its stake in shares of Loews by 2.1% during the 2nd quarter. Captrust Financial Advisors now owns 21,988 shares of the insurance provider’s stock worth $1,303,000 after acquiring an additional 458 shares in the last quarter. Legal & General Group Plc boosted its stake in shares of Loews by 2.3% during the 2nd quarter. Legal & General Group Plc now owns 2,034,208 shares of the insurance provider’s stock worth $120,547,000 after acquiring an additional 45,387 shares in the last quarter. Finally, Eagle Bay Advisors LLC bought a new stake in shares of Loews during the 2nd quarter worth about $36,000. Hedge funds and other institutional investors own 58.61% of the company’s stock.
Loews Corporation provides commercial property and casualty insurance in the United States and internationally. The company offers specialty insurance products, such as management and professional liability, and other coverage products; surety and fidelity bonds; property insurance products that include property, marine and boiler, and machinery coverages; and casualty insurance products, such as workers' compensation, general and product liability, and commercial auto and umbrella coverages.
- Get a free copy of the StockNews.com research report on Loews (L)
- 3 Banks Worth Considering For Q4
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- MarketBeat: Week in Review 9/12 – 9/16
- No One Told These 3 Stocks It’s a Down Week
- Is There a Cure for What is Ailing Teladoc Stock?
Receive News & Ratings for Loews Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Loews and related companies with MarketBeat.com's FREE daily email newsletter.